Australia markets closed

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1205+0.0139 (+13.04%)
As of 03:24PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-10,584
-14,649
-22,661
-38,298
-9,126
Depreciation & amortisation
60
60
60
32
10
Stock-based compensation
861
1,490
2,248
5,276
495
Change in working capital
360
-2,194
-55
-2,651
487
Accounts payable
-969
-442
1,007
-67
207
Other working capital
-6,789
-12,097
-20,392
-18,868
-7,928
Other non-cash items
2,334
3,228
-19
118
13
Net cash provided by operating activities
-6,769
-11,865
-20,392
-18,860
-7,928
Cash flows from investing activities
Investments in property, plant and equipment
-20
-232
-
-8
-
Net cash used for investing activities
-20
-232
0
964
0
Cash flows from financing activities
Debt repayment
-
-
0
-500
0
Common stock issued
2,624
1,903
21,569
21,598
6,583
Dividends paid
-8
-8
-8
-8
-8
Other financing activities
-
-43
-
-
-25
Net cash used provided by (used for) financing activities
2,573
1,852
21,635
26,041
6,601
Net change in cash
-4,216
-10,245
1,243
8,145
-1,327
Cash at beginning of period
4,874
11,780
10,537
2,392
3,719
Cash at end of period
658
1,535
11,780
10,537
2,392
Free cash flow
Operating cash flow
-6,769
-11,865
-20,392
-18,860
-7,928
Capital expenditure
-20
-232
-
-8
-
Free cash flow
-6,789
-12,097
-20,392
-18,868
-7,928